@mp28, yes....would expect FDA turnaround within 30 days of submitting recommended revised protocol.
-----
$100M is not what is required to finish P3..............likely to be significantly less given upfront spend on Stage 1 (including close out).
Projected $6-8m cash burn in Q4.
Parties continue to engage with PAR because of their compelling data. Its not uncommon for negotiations to become protracted.
Making outsized gains is the market is never easy....and none of us are here to convince you otherwise.
General OA media and info, page-586
-
- There are more pages in this discussion • 85 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.5¢ | 23.0¢ | $85.35K | 365.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 280011 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 44703 | 3 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |